See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Oct. 15, 2008

Memory Loss Melanoma Epilepsy

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Memory Loss

If you know someone aged 50 to 90 who has been diagnosed with probable Alzheimer's disease or has memory problems that may be a sign of Alzheimer's, is not taking any Alzheimer's medication, and has a regular caregiver who is willing to attend all trial visits, that person may qualify for this study.

The research site is in Charlotte, N.C.

More information

Please see http://www.centerwatch.com/patient/studies/cat352.html.

-----

Melanoma

If you are 18 or older, have histologically confirmed metastatic (Stage IV) melanoma of cutaneous origin, an ECOG performance status of two or less, and a life expectancy of greater than 12 weeks, you may qualify for this study.

The research site is in Cincinnati, Ohio

More information

Please see http://www.centerwatch.com/patient/studies/cat791.html.

-----

Epilepsy

If you are aged 16 to 75, have well-characterized focal epilepsy or epileptic syndrome, and are on a stable dose of one or two antiepileptic drugs, you may qualify for this study.

The research site is in Danville, Ind.

More information

Please see http://www.centerwatch.com/patient/studies/cat62.html.

-----

Copyright 2008 CenterWatch. All rights reserved.

Consumer News
undefined
undefinedundefined